The J&J opioid ruling 2019 for the case in Oklahoma has been decided.
Here’s what to know about this ruling for Johnson & Johnson (NYSE:JNJ).
The ruling wasn’t in J&J’s favor.
However, it also wasn’t near as harsh as it could have been.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,